This case study is about a phase II, double-blind, randomized, placebo controlled, dose-comparative study of the efficacy, tolerability and safety of Drug X in subjects with chronic heart failure. Through its global experience and exceptional project management, Quintiles screened 818 patients and randomized 511 within 18 months,thereby achieving all of its targets in this highly complex Proof of Concept study.